Lung cancer trials in China

In China 1143 Also abroad 2747

1,143 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
TROP2 NMR Concordance Study
Where
Beijing, Guangzhou, Shanghai
Age
18 years and over
People
3,400
Run by
AstraZeneca
See details and how to joinNCT07624318
No phaseTaking people
Station 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLC
Where
Shanghai
Age
18 years to 75 years
People
384
Run by
Fudan University
See details and how to joinNCT07801430
No phaseTaking people
Wireless Wearable Home Prehabilitation for Older Adults With NSCLC
Where
Chengdu
Age
65 years to 85 years
People
196
Run by
West China Hospital
See details and how to joinNCT07809763
Phase 1/2Taking people
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Where
Anyang, Beijing, Cangzhou, Changsha, Chengdu, Chongqing, Dalian, Guangzhou, Guanzhou, Hangzhou, Harbin, Jinan, Linyi, Luoyang, Nanchang, Nanjin, Nanjing, Nanning, Nanyang, Shanghai, Shenyang, Taiyuan, Taizhou, Tianjin, Wuhan, Xi’an, Yangzhou, Zhongshan
Age
18 years to 75 years
People
465
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07367529
Phase 1Not yet taking people in China
Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors
Where
Beijing
Age
18 years to 75 years
People
18
Run by
Beijing Anjianxi Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07806500
No phaseTaking people
Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer
Where
Beijing, Shanghai
Age
18 years and over
People
2,572
Run by
Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07806604
No phaseTaking people
Olive Oil Before Lung Cancer Surgery to Prevent Chylothorax
Where
Shanghai
Age
18 years to 80 years
People
1,036
Run by
Fudan University
See details and how to joinNCT07807696
Phase 2Not yet taking people in China
Neoadjuvant Therapy With Firmonertinib Combined With Anlotinib and Platinum-Based Doublet Chemotherapy for Resectable EGFR-Mutated NSCLC
Where
Wuhan
Age
18 years to 70 years
People
29
Run by
Hubei Cancer Hospital
See details and how to joinNCT07807722
No phaseTaking people
Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer
Where
Zhongshan
Age
18 years to 75 years
People
736
Run by
Zhongshan People's Hospital, Guangdong, China
See details and how to joinNCT05990946
Phase 1Taking people
A Phase I Study of CFT8919 in Patients With Advanced NSCLC
Where
Hangzhou
Age
18 years and over
People
166
Run by
Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT06641609
No phaseTaking people
Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces
Where
Changsha
People
500
Run by
Central South University
See details and how to joinNCT07066813
Early phase 1Taking people
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Where
Wuxi
Age
18 years to 75 years
People
10
Run by
FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07459283
No phaseTaking people
MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients
Where
Chengdu
Age
60 years to 90 years
People
2,000
Run by
West China Hospital
See details and how to joinNCT07509333
Phase 1Taking people
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Where
Beijing, Haerbin, Linyi, Shanghai
Age
18 years and over
People
400 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT04913285
No phaseTaking people
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
Where
Beijing
Age
18 years and over
People
180
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05559645
Phase 1/2Taking people
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
Where
Shanghai, Tianjin
Age
18 years and over
People
171 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT06567015 · EU 2023-510203-21-00
No phaseTaking people
Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Where
Chengdu
Age
18 years to 80 years
People
82
Run by
West China Hospital
See details and how to joinNCT07076836
Phase 2Taking people
The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients
Where
Changsha, Hengyang, Jishou
Age
18 years to 75 years
People
35
Run by
The Third Xiangya Hospital of Central South University
See details and how to joinNCT07138755
Phase 2Taking people
A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC
Where
Shanghai
Age
18 years to 75 years
People
48
Run by
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
See details and how to joinNCT07562581
Phase 2Taking people
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Guilin, Hangzhou, Harbin, Jinan, Kunming, Nanchang, Nanjing, Nanning, Shenyang, Taiyuan, Tianjin, Ürümqi, Xiamen, Xi’an, Xiangyang, Zhengzhou
Age
18 years to 75 years
People
150
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT07622186
No phaseNot yet taking people in China
Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery
Where
Chengdu
Age
18 years to 85 years
People
126
Run by
West China Hospital
See details and how to joinNCT07733492
No phaseNot yet taking people in China
Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection
Where
Chengdu
Age
18 years to 85 years
People
222
Run by
West China Hospital
See details and how to joinNCT07797075
Phase 1Taking people
A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)
Where
Guangzhou
Age
18 years and over
People
230
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06461156
Phase 1/2Taking people
DZD6008 Combination Therapy in Patients With Locally Advanced or Metastatic NSCLC With EGFR Mutation (TIAN-SHAN7)
Where
Shanghai
Age
18 years and over
People
180
Run by
Dizal Pharmaceuticals
See details and how to joinNCT07070440
Phase 1Taking people
Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)
Where
Beijing
Age
18 years and over
People
300
Run by
Dizal Pharmaceuticals
See details and how to joinNCT06813365